Omalizumab for previously treated chronic spontaneous urticaria: Urticaria (chronic spontaneous, previously treated) - omalizumab [ID707]: evaluation report and supporting information
Cited by National Institute for Health and Care Excellence on
The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.